Many investigations were carried out on the association between viruses and multiple sclerosis (MS). Indeed, early studies reported the detections of neurotropic virus footprints in the CNS of patients with MS. In this study, sera from patients affected by MS, other inflammatory (OIND) and non-inflammatory neurologic diseases (NIND) were analyzed for antibodies against the polyomavirus, Simian Virus 40 (SV40). An indirect enzyme-linked immunosorbent assay (ELISA), with two synthetic peptides, which mimic SV40 antigens, was employed to detect specific antibodies in sera from patients affected by MS, OIND, NIND and healthy subjects (HS). Immunologic data indicate that in sera from MS patients antibodies against SV40 mimotopes are detectable with a low prevalence, 6 %, whereas in HS of the same mean age, 40 yrs, the prevalence was 22%. The difference is statistically significant (P=0.001). Significant is also the difference between MS vs. NIND patients (6 % vs. 17%; P=0.0254), whereas no significant difference was detected between MS vs OIND (6 % vs 10%; P>0.05). The prevalence of SV40 antibodies in MS patients is 70% lower than that revealed in HS.
Low prevalence of antibodies against Simian Virus 40 in serum samples from patients affected by neurologic diseases, including multiple sclerosis
MAZZONI, Elisa;PIETROBON, Silvia;MASINI, Irene;ROTONDO, John Charles;GENTILE, Mauro;FAINARDI, Enrico;CASETTA, Ilaria;CASTELLAZZI, Massimiliano;GRANIERI, Enrico Gavino Giuseppe;GUERRA, Giovanni;MARTINI, Fernanda;TOGNON, Mauro
2014
Abstract
Many investigations were carried out on the association between viruses and multiple sclerosis (MS). Indeed, early studies reported the detections of neurotropic virus footprints in the CNS of patients with MS. In this study, sera from patients affected by MS, other inflammatory (OIND) and non-inflammatory neurologic diseases (NIND) were analyzed for antibodies against the polyomavirus, Simian Virus 40 (SV40). An indirect enzyme-linked immunosorbent assay (ELISA), with two synthetic peptides, which mimic SV40 antigens, was employed to detect specific antibodies in sera from patients affected by MS, OIND, NIND and healthy subjects (HS). Immunologic data indicate that in sera from MS patients antibodies against SV40 mimotopes are detectable with a low prevalence, 6 %, whereas in HS of the same mean age, 40 yrs, the prevalence was 22%. The difference is statistically significant (P=0.001). Significant is also the difference between MS vs. NIND patients (6 % vs. 17%; P=0.0254), whereas no significant difference was detected between MS vs OIND (6 % vs 10%; P>0.05). The prevalence of SV40 antibodies in MS patients is 70% lower than that revealed in HS.I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
